• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

WHO Releases Reports On Pandemic Framework Review, Implications Of Nagoya For Public Health

23/11/2016 by Catherine Saez, Intellectual Property Watch 4 Comments

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to email this to a friend (Opens in new window)
  • Click to print (Opens in new window)

The World Health Organization has published two advanced documents to be presented at the organisation’s Executive Board meeting in January. One relates to the review of the WHO mechanism for pandemic influenza preparedness, and the other to the public health implications of the implementation of an international treaty on genetic resources.

The report [pdf] of the 2016 Pandemic Influenza Preparedness Framework Review Group is expected to be presented at the WHO Executive Board meeting from 23 January to 1 February.

The agenda of the Executive Board meeting, with detailed notes on each item, is available here [pdf].

pandemic-fluIn the preface of the document, Christine Kaseba-Sata (Chair), and Theresa Tam (acting Chair), said, “The PIP Framework offers helpful insights for the sharing of other pathogens that require a rapid response and the equitable sharing of benefits.”

“However, it is the view of the PIP Framework Review Group that the PIP Framework will only remain relevant if viruses continue to be shared and the need for clarification around the sharing of genetic sequence data and benefits is rapidly addressed,” they said.

They also underlined the importance of the strengthening of capacity building and the need to increase influenza vaccine production.

Separately, a report [pdf] on how the implementation of the Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their Utilization to the Convention on Biological Diversity might affect the sharing of pathogens, and the potential public health implications was also issued as an advance document to be presented at the EB in January.

The WHO analysis found that as a central conclusion that: “(1) the Nagoya Protocol has implications for the public health response to infectious diseases, including influenza; and (2) these implications include opportunities to advance both public health and principles of fair and equitable sharing of benefits.”

 

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to email this to a friend (Opens in new window)
  • Click to print (Opens in new window)

Related

Catherine Saez may be reached at csaez@ip-watch.ch.

Creative Commons License"WHO Releases Reports On Pandemic Framework Review, Implications Of Nagoya For Public Health" by Intellectual Property Watch is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Filed Under: IP Policies, Language, Subscribers, Themes, Venues, English, Health & IP, Patents/Designs/Trade Secrets, WHO

Trackbacks

  1. WHO Board Meeting Playbook: Election Of New DG, Antimicrobial Resistance, Genetic Sequence Data - Intellectual Property Watch says:
    23/01/2017 at 10:02 am

    […] The Review Group detailed key issues needing to be addressed, in particular the handling of Genetic Sequence Data. The report also includes comments on Standard Material Transfer Agreements 2 (SMTA2) and partnership contributions (IPW, WHO, 23 November 2017). […]

    Reply
  2. World Health Assembly Topic: Flu Pandemic Financing, Virus Sharing, Extension - Intellectual Property Watch says:
    17/05/2017 at 1:40 pm

    […] The first review of the PIP Framework was carried out in 2016 by a Review Group, which provided a report in November 2016, with a number of recommendations (IPW, WHO, 23 November 2016). […]

    Reply
  3. World Health Assembly Topic: Flu Pandemic Financing, Virus Sharing, Extension - Intellectual Property Watch | Airiters says:
    17/05/2017 at 1:55 pm

    […] The first review of the PIP Framework was carried out in 2016 by a Review Group, which provided a report in November 2016, with a number of recommendations (IPW, WHO, 23 November 2016). […]

    Reply
  4. WHO Executive Board Meeting: What Are The Hot Topics? – Health Policy Watch says:
    22/01/2019 at 11:36 pm

    […] [For related stories on Intellectual Property Watch, see here, here, and here.] […]

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

IPW News Briefs

Saudis Seek Alternative Energy Partners Through WIPO Green Program

Chinese IP Officials Complete Study Of UK, European IP Law

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2022 · Global Policy Reporting

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.